An open-label, Phase 3 trial of TAK-003, a live attenuated dengue tetravalent vaccine, in healthy US adults: immunogenicity and safety when administered during the second half of a 24-month shelf-life-Reference-Cited by-同舟云学术

An open-label, Phase 3 trial of TAK-003, a live attenuated dengue tetravalent vaccine, in healthy US adults: immunogenicity and safety when administered during the second half of a 24-month shelf-life

Published:2023-08 Issue:2 Volume:19 Page:
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Patel Sanjay S.¹^ORCID,Winkle Peter²,Faccin Alice¹,Nordio Francesco³,LeFevre Inge¹,Tsoukas Claudia Galindo³

Affiliation:

1. Takeda Pharmaceuticals International AG, Zurich, Switzerland

2. Anaheim Clinical Trials, Anaheim, CA, USA

3. Takeda Pharmaceuticals International Inc., Cambridge, MA, USA

Funder

Takeda Pharmaceuticals Internation

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2023.2254964

Reference42 articles.

1. The global distribution and burden of dengue

2. Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination

3. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century

4. The future of dengue vaccines

5. World Health Organization. Dengue and severe dengue. 2023 [accessed 2023 Sep 6]. http://www.who.int/mediacentre/factsheets/fs117/en/.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trends and insights in dengue virus research globally: a bibliometric analysis (1995–2023);Journal of Translational Medicine;2024-09-03

2. An effective pan-serotype dengue vaccine and enhanced control strategies could help in reducing the severe dengue burden in Bangladesh–A perspective;Frontiers in Microbiology;2024-08-20

3. Multivalent administration of dengue E dimers on liposomes elicits type-specific neutralizing responses without immune interference;2024-08-20

4. The Urgent Need for Dengue Vaccination: Combating an Escalating Public Health Crisis in Pakistan;Vaccines;2024-08-13

5. Immunogenicity, Safety and Efficacy of the Dengue Vaccine TAK-003: A Meta-Analysis;Vaccines;2024-07-13